Effects on transmethylation by high-dose 6-mercaptopurine and methotrexate infusions during consolidation treatment of acute lymphoblastic leukemia

Biochemical Pharmacology

Volumn 51, Issue 9, 1996, Pages 1165-1171

  Keuzenkamp Jansen, Carin W ^a   De Abreu, Ronney A ^a   Blom, Henk J ^a   Bökkerink, Jos P M ^a   Trijbels, J M Frans ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

6 mercaptopurine; acute lymphoblastic leukemia; methotrexate; methylation

Indexed keywords

6 METHYLMERCAPTO 8 HYDROXYPURINE; 6 METHYLTHIOINOSINE; ADENOSINE TRIPHOSPHATE; DRUG METABOLITE; FOLINIC ACID; HOMOCYSTEINE; MERCAPTOPURINE; METHIONINE; METHOTREXATE; METHYLMERCAPTOPURINE; METHYLTHIOINOSINE NUCLEOTIDE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INFUSION; DRUG METABOLISM; ERYTHROCYTE LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHYLATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029987065     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00032-9     Document Type: Article

References (35)

1. Tidd DM and Paterson AR, A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 34: 738-746, 1974.
2. Bökkerink JPM, Stet EH, De Abreu RA, Damen FJ, Hulscher TW, Bakker MA and van Baal JM, 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol 45: 1455-1463, 1993.
3. Stet EH, De Abreu RA, Janssen YP, Bökkerink JPM and Trijbels JMF, A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line. Biochim Biophys Acta 1180: 277-282, 1993.
4. McLeod HL, Relling MV, Liu Q, Pui CH and Evans WE, Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 85: 1897-1902, 1995.
5. Van Loon JA and Weinshilboum RM, Thiopurine methyltransferase biochemical genetics: human lymphocyte activity. Biochem Genet 20: 637-658, 1982.
6. Woodson LC, Dunnette JH and Weinshilboum RM, Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies. J Pharmacol Exp Ther 222: 174-181, 1982.
7. Szumlanski CL, Honchel R, Scott MC and Weinshilboum RM, Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics 2: 148-159, 1992.
8. Weinshilboum RM and Sladek SL, Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32: 651-662, 1980.
9. Remy CN, Metabolism of thiopyrimidines and thiopurines. S-methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues. J Biol Chem 238: 1078-1084, 1963.
10. Borchardt RT, S-Adenosyl-L-methionine-dependent macromolecule methyltransferases: potential targets for the design of chemotherapeutic agents. J Med Chem 23: 347-357, 1980.
11. Finkelstein JD, Methionine metabolism in mammals. J Nutr Biochem 1: 228-236, 1990.
12. Stet EH, De Abreu RA, Bökkerink JPM, Blom HJ, Lambooy LHJ, Vogels-Mentink TM, Graaf-Hess AC de, Raay-Selten Bvan and Trijbels JMF, Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts. Biochem J 304: 163-168, 1994.
13. De Abreu RA, Lambooy LHJ, Stet EH, Vogels-Mentink TM and Heuvel Lvd, Thiopurine induced disturbance of DNA methylation in human malignant cells. Adv Enz Regul 35: 251-263, 1995.
14. Lennard L, Gibson BE, Nicole T and Lilleyman JS, Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Arch Dis Child 69: 577-579, 1993.
15. Duchesne K, Latour S, Leclerc JM, Sallan SE and Theoret Y, Pharmacokinetics of oral and intravenous 6-mercaptopurine in childhood acute lymphoblastic leukemia. Proc Am Soc Clin Oncol 13:(Abs) 137, 1995.
16. Keuzenkamp-Jansen CW, Bökkerink JPM, Trijbels JMF, Heijden MAH and De Abreu RA, Intracellular pharmacology and biochemistry of methotrexate and 6-mercaptopurine in childhood acute lymphoblastic leukemia. In: Purine and Pyrimidine Metabolism in Man VIII, (Eds. Sahota A and Taylor MW) pp. 115-118. New York: Plenum Publishing, 1995.
17. Bertino JR, Karnofsky memorial lecture. Ode to methotrexate. J Clin Oncol 11: 5-14, 1993.
18. Hershko A, Razin A and Mager J, Regulation of the synthesis of 5-phosphoribosyl-I-pyrophosphate in intact red blood cells and in cell-free preparations. Biochim Biophys Acta 184: 64-76, 1969.
19. Scholar EM and Calabresi P, Identification of the enzymatic pathways of nucleotide metabolism in human lymphocytes and leukemia cells. Cancer Res 33: 94-103, 1973.
20. Keuzenkamp-Jansen CW, De Abreu RA, Bökkerink JPM and Trijbels JMF, Determination of extracellular and intracellular thiopurines and methylthiopurines with HPLC. J Chromatogr B 672: 53-61, 1995.
21. TePoele-Pothof MWTB, Berg Mvd, Franken DG, Boers GHJ, Jakobs C, Kroon IFI de, Eskes TKAB, Trijbels JMF and Blom HJ, Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem 32: 218-220, 1995.
22. Korte Dde, Haverkort WA, van Gennip AH and Roos D, Nucleotide profiles of normal human blood cells determined by high-performance liquid chromatography. Anal Biochem 147: 197-209, 1985.
23. Laird PW and Jaenisch R, DNA methylation and cancer. Hum Mol Gen 3: 1487-1495, 1994.
24. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA and Jaenisch R, Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197-205, 1995.
25. Keuzenkamp-Jansen CW, Leegwater PAJ, De Abreu RA, Lambooy MAH, Bökkerink JPM and Trijbels JMF, Thiopurine methyltransferase activity: a review and clinical pilot study. J Chromatogr B, in press.
26. Krenitsky TA, Neil SM, Elion GB and Hitchings GH, A comparison of the specificities of xanthine oxidase and aldehyde oxidase. Arch Biochem Biophys 150: 585-599, 1972.
27. Elion GB, Biochemistry and pharmacology of purine analogs. Fed Proc 26: 898-904, 1967.
28. Elion GB, Callahan S, Rundles RW and Hitchings GH, Relationship between metabolic fates and antitumor activities of thiopurines. Cancer Res 23: 1207-1217, 1963.
29. Deininger M, Szumlanski CL, Otterness DM, Van Loon J, Ferber W and Weinshilboum RM, Purine substrates for human thiopurine methyltransferase. Biochem Pharmacol 48: 2135-2138, 1994.
30. Lagendijk J, Ubbink JB and Vermaak WJ, Quantification of erythrocyte S-adenosyl-L-methionine levels and its application in enzyme studies. J Chromatogr 576: 95-101, 1992.
31. Barber JR, Morimoto BH, Brunauer LS and Clarke S, Metabolism of S-adenosyl-L-methionine in intact human erythrocytes. Biochim Biophys Acta 886: 361-372, 1986.
32. Oden KL and Clarke S, S-adenosyl-L-methionine synthetase from human erythrocytes: role in the regulation of cellular S-adenosylmethionine levels. Biochemistry 22: 2978-2986, 1983.
33. Refsum H, Ueland PM and Kvinnsland S, Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res 46: 5385-5391, 1986.
34. Refsum H, Wesenberg F and Ueland PM, Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res 51: 828-835, 1991.
35. Broxson EHJ, Stork LC, Allen RH, Stabler SP and Kolhouse JF, Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res 49: 5879-5883, 1989.